Actualité - Découvrez les nouveautés !
Vous trouvez ici les dernières nouveautés concernant les événements, les développements de produits et les publications de l'entreprise.
The importance of multimodal imaging in the diagnosis of AMD and geographic atrophy
The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.
En savoir plus
Heidelberg Engineering startet mit neuem Vertriebspartner in der Türkei
Seit dem 1. Januar 2023 übernimmt unser neuer offizieller Partner, OCULAMED Medikal Elektronik Ltd. Sti., die Distribution unseres wachsenden Produktportfolios in der Türkei und wird weiterhin den hohen Standard an Service und Weiterbildung anbieten, den Heidelberg Engineering Kund:innen gewohnt sind.
En savoir plus
OIS Podcast Episode on Heidelberg Engineering: Setting the Standards in Imaging
Sophia Pathai, MD, PhD, host of the Ophthalmic Innovation Source podcast, caught up with our Head of Corporate Strategy and Managing Director of MSI, Kfir Azoulay, as well as Tosh Vadhia, Managing Director of Heidelberg Engineering UK, to talk about the trends and opportunities in ophthalmology, including OCT-based biomarkers and artificial intelligence.
En savoir plus
Heidelberg Engineering announces website launch of consortium dedicated to improving glaucoma detection
Heidelberg Engineering, an industry partner of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), welcomes the unveiling of the consortium’s official website.
En savoir plus
Benefits of OCT before Cataract Surgery
Dr. Farrell "Toby" Tyson overviews his pre-surgery cataract workup routine and discusses his preference of imaging with SPECTRALIS as part of his patient screening process.
En savoir plus
Diagnosing and Treating Glaucoma webinar with Swarup Swaminathan, MD
Learn how to optimize the use of SPECTRALIS in your glaucoma practice and how to identify masqueraders that often get mistakenly treated as glaucoma.
En savoir plus
Approaches to Reviewing OCTA Images of CNV with Dr. Karl Csaky Online Webinar
During the webinar, Dr. Csaky presented four case presentations showcasing the value of OCTA imaging in clinical practice.
En savoir plus
Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study
In this peer-reviewed long term, prospective study of patients with intermittent multiple sclerosis published in the Annals of Clinical and Translational Neurology, SPECTRALIS OCT was used to image inner retinal layers with the authors noting, “OCT has potential to estimate rates of neurodegeneration in the retina and brain.”
En savoir plus
Dr. Sergott Discusses Benefits of MultiColor Fundus Imaging at AAO
Neuro-ophthalmologist Dr. Robert (Bob) Sergott discusses with Healio| OSN the clinical value of MultiColor fundus imaging with SPECTRALIS® at the annual American Academy of Ophthalmology meeting in New Orleans, LA.
En savoir plus
What Multimodal Imaging Can Reveal with the Unclear Diagnosis Webinar
Dr. Vakharia (Retina Vitreous Associates of Florida) educates on how a combination of Multimodal diagnostic imaging can demystify challenging cases and increase clinical confidence.
En savoir plus